What question did this study set out to answer?

This study aims to evaluate the relationship between hydroxychloroquine blood levels, long-term intake, and ASCVD risk in patients with systemic lupus erythematosus.

August 5, 2026Arthritis Care & ResearchOpen Access

Optimizing Hydroxychloroquine Blood Levels and Long‐Term Hydroxychloroquine Intake Could Lower ASCVD Risk and Prevent Polypharmacy in Systemic Lupus Erythematosus

View Full Paper

Ask AI

Bookmark

This study aims to evaluate the relationship between hydroxychloroquine blood levels, long-term intake, and ASCVD risk in patients with systemic lupus erythematosus.
Prospective longitudinal study of 248 adults with systemic lupus erythematosus in Wisconsin
Hydroxychloroquine exposure was measured using whole-blood levels and proportion of days covered
ASCVD risk was calculated at baseline and one year follow-up using the PREVENT calculator and analyzed via multivariable linear regression.
Patients with very low HCQ blood levels (<200 ng/mL) and low intake (PDC <80%) had a baseline ASCVD risk increase of +2.1%, mean predicted risk 6.6%.
Those remaining in low-exposure categories had the highest ASCVD risk (5.7%) at one-year follow-up.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Prospective trial finds maintaining appropriate hydroxychloroquine levels lowers ASCVD risk in systemic lupus erythematosus, suggesting improved adherence is crucial.

Cite This Study

Garg et al. (2026) studied this question.

synapsesocial.com/papers/6a72e85b226790f370658409 https://doi.org/10.1002/acr.80128

View Full Paper

Ask AI

Bookmark

Implication

Prospective trial finds maintaining appropriate hydroxychloroquine levels lowers ASCVD risk in systemic lupus erythematosus, suggesting improved adherence is crucial.

Optimizing Hydroxychloroquine Blood Levels and Long‐Term Hydroxychloroquine Intake Could Lower ASCVD Risk and Prevent Polypharmacy in Systemic Lupus Erythematosus

Key Points

Discussion

Implication

Cite This Study

Optimizing Hydroxychloroquine Blood Levels and Long‐Term Hydroxychloroquine Intake Could Lower ASCVD Risk and Prevent Polypharmacy in Systemic Lupus Erythematosus

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider